Aaron Noyes

Aaron Noyes has extensive work experience in the field of biotechnology and chemical engineering. Aaron'smost recent position is Vice President of Integrated Drug Substance Development at Codiak BioSciences, where they have been since October 2021. Prior to this role, they served as the Senior Director and Head of Integrated Drug Substance Development at Codiak BioSciences from January to October 2021. In their previous role as Director of Downstream Processing at Codiak BioSciences from January 2020 to January 2021, Aaron led teams in inventing, optimizing, and scaling-up purification processes for advanced exosome therapeutics and other biotherapeutic products.

Before joining Codiak BioSciences, Aaron worked at Pfizer Biotech as a Process Engineer from October 2009 to July 2016, and as a Biochemical Engineer from February 2005 to December 2010. At Pfizer, they gained experience in process engineering and biochemical engineering.

In addition to their industry experience, Aaron has also worked in academia. Aaron served as an Adjunct Faculty at the University of Massachusetts Lowell, Department of Chemical Engineering from January to May 2016, and as an Adjunct Instructor at Tufts University, Department of Chemical and Biological Engineering from January to May 2013.

Earlier in their career, Aaron worked at Millipore Corporation as a Development Engineer. Aaron'sresponsibilities included designing and optimizing process chromatography systems and developing filtration applications. Aaron was with the company from 2000 to 2005.

Overall, Aaron Noyes has a diverse background in biotechnology and chemical engineering, with expertise in drug substance development, downstream processing, process engineering, and academia.

Aaron Noyes pursued their education in various institutions. Aaron began in 1997 at the University of Massachusetts Amherst, where they obtained a Bachelor of Science degree in Biochemistry in 2001. In 1999, they briefly attended the University of Wollongong, although no degree or field of study information was provided. Continuing their studies, Noyes enrolled at Tufts University from 2003 to 2006, where they earned a Master of Engineering degree in Biotech Engineering. Following this, they moved to UCL, attending from 2010 to 2011, completing their Master of Research degree in Biochemical Engineering. Finally, Noyes pursued a higher level of education by undertaking an Engineering Doctorate program in Biochemical Engineering at UCL from 2011 to 2014.